Cargando…

Tumor Infiltration Levels of CD3, Foxp3 (+) Lymphocytes and CD68 Macrophages at Diagnosis Predict 5-Year Disease-Specific Survival in Patients with Oropharynx Squamous Cell Carcinoma

SIMPLE SUMMARY: Head and neck cancer (HNC) is the sixth most common cancer worldwide, with a general prognosis of 50% disease-specific survival (DSS). The subgroup of oropharyngeal (OP) cancers are of interest because HPV infection is one of several causative agents and carries favorable prognosis....

Descripción completa

Detalles Bibliográficos
Autores principales: Ljokjel, Borghild, Haave, Hilde, Lybak, Stein, Vintermyr, Olav Karsten, Helgeland, Lars, Aarstad, Hans Jørgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946734/
https://www.ncbi.nlm.nih.gov/pubmed/35326661
http://dx.doi.org/10.3390/cancers14061508
_version_ 1784674262623191040
author Ljokjel, Borghild
Haave, Hilde
Lybak, Stein
Vintermyr, Olav Karsten
Helgeland, Lars
Aarstad, Hans Jørgen
author_facet Ljokjel, Borghild
Haave, Hilde
Lybak, Stein
Vintermyr, Olav Karsten
Helgeland, Lars
Aarstad, Hans Jørgen
author_sort Ljokjel, Borghild
collection PubMed
description SIMPLE SUMMARY: Head and neck cancer (HNC) is the sixth most common cancer worldwide, with a general prognosis of 50% disease-specific survival (DSS). The subgroup of oropharyngeal (OP) cancers are of interest because HPV infection is one of several causative agents and carries favorable prognosis. Influxes of inflammatory cells into tumors may vary with prognosis. T lymphocytes are important regarding specific immune defense. Within the immune system T regulatory cells (Foxp3 positive) co-governs this process. We have therefore primarily studied levels of Foxp3 (+) cells in malignant tumors from 170 patients related to prognosis of the patients. Higher levels of T lymphocyte Foxp3 (+) cells predicted better 5-year DSS. This case was unique relative to age, gender, TNM stage, and HPV infection; but more so among tumor HPV (+) than HPV (−) patients. The results encourage further study into the use of immune-based therapy in HNC patients. ABSTRACT: Head and neck cancer (HNC) is the sixth most common cancer worldwide. Oropharyngeal (OP) cancers are of special interest because of possible underlying HPV infection which is tied to prognosis. Influxes of inflammatory cells into tumors may vary with prognoses. We wanted to study whether the number of tumor-infiltrating lymphocytes (TIL) and tumor-associated macrophages (TAM) in tumors correlated to HPV status and predicted 5-year disease-specific survival (DSS). Formalin-fixed paraffin-embedded (FFPE) biopsies cut sections from 170 patients treated for OP cancer were stained by immunohistochemistry and evaluated for the number of CD68 (+) TAMs, CD3 (+), and Foxp3 (+) (T regulatory) TILs. From FFPE slides HPV by PCR and p16 by immunohistochemistry were established. From FFPE Hematoxylin-Eosin slides, levels of tumor nuclear polymorphism, tumor invasion, desmoplasia, and inflammation were determined as previously published. Levels of TIL CD3 (+) and TIL Foxp3 (+) were increased among the HPV (+) compared to the HPV (−) patients. High levels of TIL Foxp3 (+) and CD68 (+) macrophages predicted better 5-year DSS. TIL Foxp3 (+) levels predicted independent of age, gender, TNM stage, and HPV infection as well as level of stromal desmoplasia, tumor invasion, and nuclear polymorphism, but more pronounced among tumor HPV (+) than HPV (−) patients.
format Online
Article
Text
id pubmed-8946734
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89467342022-03-25 Tumor Infiltration Levels of CD3, Foxp3 (+) Lymphocytes and CD68 Macrophages at Diagnosis Predict 5-Year Disease-Specific Survival in Patients with Oropharynx Squamous Cell Carcinoma Ljokjel, Borghild Haave, Hilde Lybak, Stein Vintermyr, Olav Karsten Helgeland, Lars Aarstad, Hans Jørgen Cancers (Basel) Article SIMPLE SUMMARY: Head and neck cancer (HNC) is the sixth most common cancer worldwide, with a general prognosis of 50% disease-specific survival (DSS). The subgroup of oropharyngeal (OP) cancers are of interest because HPV infection is one of several causative agents and carries favorable prognosis. Influxes of inflammatory cells into tumors may vary with prognosis. T lymphocytes are important regarding specific immune defense. Within the immune system T regulatory cells (Foxp3 positive) co-governs this process. We have therefore primarily studied levels of Foxp3 (+) cells in malignant tumors from 170 patients related to prognosis of the patients. Higher levels of T lymphocyte Foxp3 (+) cells predicted better 5-year DSS. This case was unique relative to age, gender, TNM stage, and HPV infection; but more so among tumor HPV (+) than HPV (−) patients. The results encourage further study into the use of immune-based therapy in HNC patients. ABSTRACT: Head and neck cancer (HNC) is the sixth most common cancer worldwide. Oropharyngeal (OP) cancers are of special interest because of possible underlying HPV infection which is tied to prognosis. Influxes of inflammatory cells into tumors may vary with prognoses. We wanted to study whether the number of tumor-infiltrating lymphocytes (TIL) and tumor-associated macrophages (TAM) in tumors correlated to HPV status and predicted 5-year disease-specific survival (DSS). Formalin-fixed paraffin-embedded (FFPE) biopsies cut sections from 170 patients treated for OP cancer were stained by immunohistochemistry and evaluated for the number of CD68 (+) TAMs, CD3 (+), and Foxp3 (+) (T regulatory) TILs. From FFPE slides HPV by PCR and p16 by immunohistochemistry were established. From FFPE Hematoxylin-Eosin slides, levels of tumor nuclear polymorphism, tumor invasion, desmoplasia, and inflammation were determined as previously published. Levels of TIL CD3 (+) and TIL Foxp3 (+) were increased among the HPV (+) compared to the HPV (−) patients. High levels of TIL Foxp3 (+) and CD68 (+) macrophages predicted better 5-year DSS. TIL Foxp3 (+) levels predicted independent of age, gender, TNM stage, and HPV infection as well as level of stromal desmoplasia, tumor invasion, and nuclear polymorphism, but more pronounced among tumor HPV (+) than HPV (−) patients. MDPI 2022-03-15 /pmc/articles/PMC8946734/ /pubmed/35326661 http://dx.doi.org/10.3390/cancers14061508 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ljokjel, Borghild
Haave, Hilde
Lybak, Stein
Vintermyr, Olav Karsten
Helgeland, Lars
Aarstad, Hans Jørgen
Tumor Infiltration Levels of CD3, Foxp3 (+) Lymphocytes and CD68 Macrophages at Diagnosis Predict 5-Year Disease-Specific Survival in Patients with Oropharynx Squamous Cell Carcinoma
title Tumor Infiltration Levels of CD3, Foxp3 (+) Lymphocytes and CD68 Macrophages at Diagnosis Predict 5-Year Disease-Specific Survival in Patients with Oropharynx Squamous Cell Carcinoma
title_full Tumor Infiltration Levels of CD3, Foxp3 (+) Lymphocytes and CD68 Macrophages at Diagnosis Predict 5-Year Disease-Specific Survival in Patients with Oropharynx Squamous Cell Carcinoma
title_fullStr Tumor Infiltration Levels of CD3, Foxp3 (+) Lymphocytes and CD68 Macrophages at Diagnosis Predict 5-Year Disease-Specific Survival in Patients with Oropharynx Squamous Cell Carcinoma
title_full_unstemmed Tumor Infiltration Levels of CD3, Foxp3 (+) Lymphocytes and CD68 Macrophages at Diagnosis Predict 5-Year Disease-Specific Survival in Patients with Oropharynx Squamous Cell Carcinoma
title_short Tumor Infiltration Levels of CD3, Foxp3 (+) Lymphocytes and CD68 Macrophages at Diagnosis Predict 5-Year Disease-Specific Survival in Patients with Oropharynx Squamous Cell Carcinoma
title_sort tumor infiltration levels of cd3, foxp3 (+) lymphocytes and cd68 macrophages at diagnosis predict 5-year disease-specific survival in patients with oropharynx squamous cell carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946734/
https://www.ncbi.nlm.nih.gov/pubmed/35326661
http://dx.doi.org/10.3390/cancers14061508
work_keys_str_mv AT ljokjelborghild tumorinfiltrationlevelsofcd3foxp3lymphocytesandcd68macrophagesatdiagnosispredict5yeardiseasespecificsurvivalinpatientswithoropharynxsquamouscellcarcinoma
AT haavehilde tumorinfiltrationlevelsofcd3foxp3lymphocytesandcd68macrophagesatdiagnosispredict5yeardiseasespecificsurvivalinpatientswithoropharynxsquamouscellcarcinoma
AT lybakstein tumorinfiltrationlevelsofcd3foxp3lymphocytesandcd68macrophagesatdiagnosispredict5yeardiseasespecificsurvivalinpatientswithoropharynxsquamouscellcarcinoma
AT vintermyrolavkarsten tumorinfiltrationlevelsofcd3foxp3lymphocytesandcd68macrophagesatdiagnosispredict5yeardiseasespecificsurvivalinpatientswithoropharynxsquamouscellcarcinoma
AT helgelandlars tumorinfiltrationlevelsofcd3foxp3lymphocytesandcd68macrophagesatdiagnosispredict5yeardiseasespecificsurvivalinpatientswithoropharynxsquamouscellcarcinoma
AT aarstadhansjørgen tumorinfiltrationlevelsofcd3foxp3lymphocytesandcd68macrophagesatdiagnosispredict5yeardiseasespecificsurvivalinpatientswithoropharynxsquamouscellcarcinoma